Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: Treatment patterns and cost of exacerbations in patients with chronic obstructive pulmonary disease using multiple inhaler triple therapy in South Korea

Fig. 2

Patient flow and eligibility criteria. Index date was defined as the first overlapping day of supply with all three COPD medications of the MITT regimen; patients’ index date was ≥ 12 months prior to data cutoff. COPD: chronic obstructive pulmonary disease; ER: emergency room; ICS: inhaled corticosteroid; LABA: long-acting beta agonist; LAMA: long-acting muscarinic antagonist; MITT: multiple inhaler triple therapy

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us